Skip to content

Study · Not a test of the peptide alone · 1989

2 results

MicroELISA method for the determination of thymosin beta 9 discriminating between thymosin beta 9 and the structurally closely related thymosin beta 4.

Mihelić M, Kalbacher H, Hannappel E, Voelter W

Journal of immunological methods1 Aug 1989Cited by 12 (Europe PMC)

PMID2760477 (opens in a new tab)DOI10.1016/0022-1759(89)90328-1 (opens in a new tab)PepBankPUB-02760477
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymosin beta-4 (human).

  1. 01LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    In a competitive ELISA, antibodies raised against the N-terminal fragment 1-14 of thymosin beta 9 showed less than 1% cross-reactivity with thymosin beta‑4.

    In plain wordsIn lab tests, an antibody made for thymosin beta 9 reacted with thymosin beta‑4 by less than 1%.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableCross-reactivity of antibodies to thymosin beta 9 fragment 1-14 with thymosin beta 4
    Study

    n: not reported in source

    competitive ELISA
    Outcome group
    Analytical methods and detection · Pharmacology

    Measurements

    cross-reactivity
    < 1%
    antibodies against thymosin beta 9 fragment 1-14

    Source sentences

    Summary
    These antibodies have been tested in a competitive ELISA and show less than 1% cross-reactivity with thymosin beta 4.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

  2. 02LabNot a test of Thymosin beta-4 (human) aloneIn vitro (cell-free)Other

    Antibodies raised against native thymosin beta 9 (1-14) cross-reacted 35% with thymosin beta‑4.

    In plain wordsIn lab tests, an antibody made against the native thymosin beta 9 fragment reacted with thymosin beta‑4 by 35%.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    Not applicableCross-reactivity of antibodies to native thymosin beta 9 (1-14) with thymosin beta 4
    Study

    n: not reported in source

    competitive ELISA
    Outcome group
    Analytical methods and detection · Pharmacology

    Measurements

    cross-reactivity
    35%
    antibodies against native thymosin beta 9 (1-14)

    Source sentences

    Summary
    On the other hand, antibodies raised against the native thymosin beta 9 (1-14) cross-react 35% with thymosin beta 4.

    In this study, Thymosin beta-4 (human) was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymosin beta-4 (human).

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.